Hiruma Y - Search Results

1

Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.

Teramachi J, Hiruma Y, Ishizuka S, Ishizuka H, Brown JP, Michou L, Cao H, Galson DL, Subler MA, Zhou H, Dempster DW, Windle JJ, Roodman GD, Kurihara N. Teramachi J, et al. Among authors: hiruma y. J Bone Miner Res. 2013 Jun;28(6):1489-500. doi: 10.1002/jbmr.1884. J Bone Miner Res. 2013. PMID: 23426901 Free PMC article. Clinical Trial.

2

A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.

Hiruma Y, Kurihara N, Subler MA, Zhou H, Boykin CS, Zhang H, Ishizuka S, Dempster DW, Roodman GD, Windle JJ. Hiruma Y, et al. Hum Mol Genet. 2008 Dec 1;17(23):3708-19. doi: 10.1093/hmg/ddn266. Epub 2008 Sep 2. Hum Mol Genet. 2008. PMID: 18765443 Free PMC article.

3

Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling.

Wang FM, Sarmasik A, Hiruma Y, Sun Q, Sammut B, Windle JJ, Roodman GD, Galson DL. Wang FM, et al. Among authors: hiruma y. Bone. 2013 Mar;53(1):269-76. doi: 10.1016/j.bone.2012.12.007. Epub 2012 Dec 20. Bone. 2013. PMID: 23262029 Free PMC article.

4

Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.

Kurihara N, Hiruma Y, Zhou H, Subler MA, Dempster DW, Singer FR, Reddy SV, Gruber HE, Windle JJ, Roodman GD. Kurihara N, et al. Among authors: hiruma y. J Clin Invest. 2007 Jan;117(1):133-42. doi: 10.1172/JCI28267. Epub 2006 Dec 21. J Clin Invest. 2007. PMID: 17187080 Free PMC article.

5

Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.

Kurihara N, Hiruma Y, Yamana K, Michou L, Rousseau C, Morissette J, Galson DL, Teramachi J, Zhou H, Dempster DW, Windle JJ, Brown JP, Roodman GD. Kurihara N, et al. Among authors: hiruma y. Cell Metab. 2011 Jan 5;13(1):23-34. doi: 10.1016/j.cmet.2010.12.002. Cell Metab. 2011. PMID: 21195346 Free PMC article.

6

1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.

Ishizuka S, Kurihara N, Hiruma Y, Miura D, Namekawa J, Tamura A, Kato-Nakamura Y, Nakano Y, Takenouchi K, Hashimoto Y, Nagasawa K, Roodman GD. Ishizuka S, et al. Among authors: hiruma y. J Steroid Biochem Mol Biol. 2008 Jun;110(3-5):269-77. doi: 10.1016/j.jsbmb.2007.11.007. Epub 2008 Apr 22. J Steroid Biochem Mol Biol. 2008. PMID: 18501591 Free PMC article.

7

Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation.

Hiruma Y, Honjo T, Jelinek DF, Windle JJ, Shin J, Roodman GD, Kurihara N. Hiruma Y, et al. Blood. 2009 May 14;113(20):4894-902. doi: 10.1182/blood-2008-08-173948. Epub 2009 Mar 12. Blood. 2009. PMID: 19282458 Free PMC article.

8

Ipriflavone down-regulates endothelin receptor levels during differentiation of rat calvarial osteoblast-like cells.

Hagiwara H, Naruse M, Adachi C, Inoue A, Hiruma Y, Otsuka E, Naruse K, Demura H, Hirose S. Hagiwara H, et al. Among authors: hiruma y. J Biochem. 1999 Jul;126(1):168-73. doi: 10.1093/oxfordjournals.jbchem.a022418. J Biochem. 1999. PMID: 10393335 Free article.

We reported previously that endothelin-1 inhibits the differentiation of ROB cells [Y. Hiruma et al. (1998) J. Cardiovasc. Pharmacol. 31, S521-S523]. Therefore, we examined the effects of ipriflavone on the expression of endothelin receptors in ROB cells by polymera …

We reported previously that endothelin-1 inhibits the differentiation of ROB cells [Y. Hiruma et al. (1998) J. Cardiovasc. Pha …

9

Vasoactive peptide-regulated gene expression during osteoblastic differentiation.

Inoue A, Kamiya A, Ishiji A, Hiruma Y, Hirose S, Hagiwara H. Inoue A, et al. Among authors: hiruma y. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S286-9. doi: 10.1097/00005344-200036051-00084. J Cardiovasc Pharmacol. 2000. PMID: 11078400

10

Vitamin K2 and geranylgeraniol, its side chain component, inhibited osteoclast formation in a different manner.

Hiruma Y, Nakahama K, Fujita H, Morita I. Hiruma Y, et al. Biochem Biophys Res Commun. 2004 Jan 30;314(1):24-30. doi: 10.1016/j.bbrc.2003.12.051. Biochem Biophys Res Commun. 2004. PMID: 14715241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters